Bharat Biotech begins first phase of human trials of indigenously developed Covaxin

Covaxin has been in news since ICMR director-general Balram Bhargava shot off a letter on July 2 to 12 hospitals and research centres, asking them to enrol subjects for human trials of Covaxin, so that the vaccine is ready for public use by August 15.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news